62 related articles for article (PubMed ID: 18341386)
1. Shifting the balance: cell-based therapeutics as modifiers of the amyotrophic lateral sclerosis-specific neuronal microenvironment.
Riley J; Sweeney W; Boulis N
Neurosurg Focus; 2008; 24(3-4):E10. PubMed ID: 18341386
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cells in modeling and cell-based therapy of amyotrophic lateral sclerosis.
Csobonyeiova M; Polak S; Nicodemou A; Danisovic L
J Physiol Pharmacol; 2017 Oct; 68(5):649-657. PubMed ID: 29375039
[TBL] [Abstract][Full Text] [Related]
3. The dual roles of immunity in ALS: injury overrides protection.
Murdock BJ; Bender DE; Segal BM; Feldman EL
Neurobiol Dis; 2015 May; 77():1-12. PubMed ID: 25726748
[TBL] [Abstract][Full Text] [Related]
4. The role of glial cells in amyotrophic lateral sclerosis.
Pandya VA; Patani R
Int Rev Neurobiol; 2024; 176():381-450. PubMed ID: 38802179
[TBL] [Abstract][Full Text] [Related]
5. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
6. Stem cell therapy in amyotrophic lateral sclerosis.
Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
[TBL] [Abstract][Full Text] [Related]
7. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
[TBL] [Abstract][Full Text] [Related]
8. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis.
Sargsyan SA; Monk PN; Shaw PJ
Glia; 2005 Sep; 51(4):241-53. PubMed ID: 15846792
[TBL] [Abstract][Full Text] [Related]
9. Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease?
Neusch C; Bähr M; Schneider-Gold C
Muscle Nerve; 2007 Jun; 35(6):712-24. PubMed ID: 17373702
[TBL] [Abstract][Full Text] [Related]
10. The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis.
Nonneman A; Robberecht W; Van Den Bosch L
Neurodegener Dis Manag; 2014; 4(3):223-39. PubMed ID: 25095817
[TBL] [Abstract][Full Text] [Related]
11. New therapeutic targets for amyotrophic lateral sclerosis.
Kuzma-Kozakiewicz M; Kwiecinski H
Expert Opin Ther Targets; 2011 Feb; 15(2):127-43. PubMed ID: 21133819
[TBL] [Abstract][Full Text] [Related]
12. [Amyotrophic lateral sclerosis--electrophysiologic aspects of its pathophysiology and new therapeutic options].
Kuwabara S
Brain Nerve; 2010 Aug; 62(8):885-91. PubMed ID: 20714037
[TBL] [Abstract][Full Text] [Related]
13. N-acetyl-l-tryptophan, but not N-acetyl-d-tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis.
Sirianni AC; Jiang J; Zeng J; Mao LL; Zhou S; Sugarbaker P; Zhang X; Li W; Friedlander RM; Wang X
J Neurochem; 2015 Sep; 134(5):956-68. PubMed ID: 26031348
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophic factors and amyotrophic lateral sclerosis.
Ekestern E
Neurodegener Dis; 2004; 1(2-3):88-100. PubMed ID: 16908980
[TBL] [Abstract][Full Text] [Related]
15. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis.
Suzuki M; Svendsen CN
Trends Neurosci; 2008 Apr; 31(4):192-8. PubMed ID: 18329734
[TBL] [Abstract][Full Text] [Related]
16. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
[TBL] [Abstract][Full Text] [Related]
17. Electroacupuncture reduces neuroinflammatory responses in symptomatic amyotrophic lateral sclerosis model.
Yang EJ; Jiang JH; Lee SM; Hwang HS; Lee MS; Choi SM
J Neuroimmunol; 2010 Jun; 223(1-2):84-91. PubMed ID: 20460191
[TBL] [Abstract][Full Text] [Related]
18. Role of Renshaw cells in amyotrophic lateral sclerosis.
Mazzocchio R; Rossi A
Muscle Nerve; 2010 Apr; 41(4):441-3. PubMed ID: 20082418
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic mechanisms in amyotrophic lateral sclerosis.
Sandyk R
Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
[TBL] [Abstract][Full Text] [Related]
20. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
Yoo YE; Ko CP
Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
